Duplicate subjects and professional subjects in clinical trials are a global issue. No region or study is immune to these issues. VCT is now utilized in more than 50 countries around the globe. VCT has crafted processes to comply with local regulatory and ethics committees globally specifically tailored for each country and region’s local regulatory and legal requirements. Unmatched technology and processes have allowed VCT to become the world’s only global research subject database. Protections begin in phase I and continue through phase IV across numerous therapeutic indications.
VCT offers at home facial recognition verification capabilities to eliminate duplicate and professional research subjects. Great for virtual and de-centralized clinical trials or even clinical trials conducted at the site. What are the advantages of this technology?